Abstract
Background
The present study was carried out to clarify the clinicopathological features of hepatocellular carcinoma (HCC) patients with chronic schistosomiasis japonica (SJ) who underwent hepatic resection. Furthermore, we also analyzed the impact of chronic SJ on survival after hepatic resection.
Methods
During the last 10 years in our department, 198 patients have undergone hepatic resection for HCC. Forty-four patients were diagnosed as having chronic SJ by histological examination. Clinicopathological features and survival were retrospectively analyzed.
Results
Age in the SJ group was significantly higher than in the non-SJ group. In the SJ group, positivity to HBsAg (hepatitis B surface antigen) was significantly lower than in the non-SJ group, and patients more often developed intrahepatic cholangiocellular carcinoma (or cholangiolocellular carcinoma) than in the non-SJ group. Greatest tumor dimension in the SJ group was significantly larger than in the non-SJ group. Univariate analysis revealed that chronic SJ, prothrombin time 80% or less and Child-Pugh B, des-γ-carboxyprothrombin (DCP) level >40 milli-arbitrary units (mAU)/ml, tumor diameter of more than 5.0 cm, multiple tumors, vascular invasion, intrahepatic metastasis, advanced T stage (T2–4), and non-curative resection were associated with significantly worse overall survival. By multivariate analysis, chronic SJ, Child-Pugh B, advanced T stage, and non-curative resection were independent predictors of the adverse overall survival of HCC patients after hepatic resection.
Conclusions
Patients with chronic SJ were older, had larger HCC, and were more often complicated by cholangiocellular carcinoma (or cholangiolocellular carcinoma) than non-SJ patients. Chronic SJ was an independent adverse prognostic factor for survival after hepatic resection in HCC patients.
Similar content being viewed by others
References
World Health Organization (2009) Schistosomiasis. World Health Organization, Geneva. http://www.who.int/schistosomiasis/en/. Accessed 2009
Minai M, Hosaka Y, Ohta N (2003) Historical view of schistosomiasis japonica in Japan: implementation and evaluation of disease-control strategies in Yamanashi Prefecture. Parasitol Int 52:321–326
Iida F, Iida R, Kamijo H et al (1999) Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan. Bull World Health Organ 77:573–581
Nakashima T, Okuda K, Kojiro M et al (1975) Primary liver cancer coincident with schistosomiasis japonica. A study of 24 necropsies. Cancer 36:1483–1489
Kojiro M, Kakizoe S, Yano H et al (1986) Hepatocellular carcinoma and schistosomiasis japonica. A clinicopathologic study of 59 autopsy cases of hepatocellular carcinoma associated with chronic schistosomiasis japonica. Acta Pathol Jpn 36:525–532
Uchimura Y, Sata M, Suzuki H et al (1997) High prevalence of hepatitis C virus infection in schistosomiasis japonica patients associated with hepatocellular carcinoma. Int J Oncol 11:1103–1107
Pugh RNH, Murray-Lyon IM, Dawson JL (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–669
Couinaud C (1957) Le Foie. Etudes anatomiques et chirurgicales. Masson, Paris
Ohmae H, Sy OS, Chigusa Y et al (2003) Imaging diagnosis of schistosomiasis japonica—the use in Japan and application for field study in the present endemic area. Parasitol Int 52:385–393
Nakashima T, Kage M, Hirata M (2003) A historical view of schistosomiasis japonica in the Chikugo river basin. What can we learn from autopsy? Parasitol Int 52:327–334
American Joint Committee on Cancer (AJCC) (2002) AJCC cancer staging manual, 6th edn. Springer, New York
Inaba Y, Maruchi N, Matsuda M et al (1984) A case-control study on liver cancer with special emphasis on the possible aetiological role of schistosomiasis. Int J Epidemiol 13:408–412
Kitani K, Iuchi M (1990) Schistosomiasis japonica: a vanishing endemic in Japan. J Gastroenterol Hepatol 5:160–172
Takemura Y, Kikuchi S, Inaba Y (1998) Epidemiologic study of the relationship between schistosomiasis due to Schistosoma japonicum and liver cancer/cirrhosis. Am J Trop Med Hyg 59:551–556
Tanaka Y, Hanada K, Orito E et al (2005) Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. J Hepatol 42:47–53
Amano T, Oshima T (1998) Hepatoma formation in ddY mice with chronic schistosomiasis japonica. Jpn J Cancer Res 79:173–180
Ishii A, Matsuoka H, Aji T et al (1994) Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review. Mutat Res 305:273–281
Watanapa P, Watanapa WB (2002) Liver fluke-associated cholangiocarcinoma. Br J Surg 89:962–970
Lim MK, Ju YH, Franceschi S et al (2006) Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg 75:93–96
Andoh H, Yasui O, Kurokawa T et al (2004) Cholangiocarcinoma coincident with schistosomiasis japonica. J Gastroenterol 39:64–68
Matsuda M, Hara M, Suzuki T et al (2006) Synchronously resected double primary hepatic cancers—hepatocellular carcinoma and cholangiolocellular carcinoma. J Hepatobiliary Pancreat Surg 13:571–576
Akatsu T, Shimazu M, Shinoda M et al (2007) Intrahepatic cholangiocarcinoma with old infestation of Schistosoma japonicum: report of a case. Surg Today 37:905–909
Kamal S, Madwar M, Bianchi L et al (2000) Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20:281–289
Strickland GT (2006) Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43:915–922
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsuda, M., Fujii, H. Chronic Schistosomiasis Japonica is an Independent Adverse Prognostic Factor for Survival in Hepatocellular Carcinoma Patients Who Have Undergone Hepatic Resection: Clinicopathological and Prognostic Analysis of 198 Consecutive Patients. World J Surg 33, 2644–2650 (2009). https://doi.org/10.1007/s00268-009-0228-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0228-7